Savannah Weedman, MD
Oral and Maxillofacial Surgery · Phoenix, AZNPI 1770802613
Payments from drug & device makers
What this record shows
Axogen accounts for 78.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $2,933 and has fallen 95.9% since, to $120 in 2025.
Across 20 payments — averaging $159.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$2K
- Johnson & Johnson$222
- Stryker$218
- Kls-martin L.p.$204
- Daiichi Sankyo Inc.$16
- Smith+Nephew$14
- plus $13 from 1 others
What the payments were for
- Travel & lodging$1,52848%
- Food & beverage$1,65752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 5 | $2,498 |
| Johnson & Johnson | 4 | $222 |
| Stryker | 3 | $218 |
| Kls-martin L.p. | 5 | $204 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Sanofi | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Connector$2,498
- AxoGuard Nerve Protector$2,498
- VSP ORTHOGNATHIC$136
How this compares
$3,185 in reported general payments places this provider in the 75th percentile of 147 oral and maxillofacial surgery providers in Arizona.
See all oral and maxillofacial surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 21 | $102 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Phoenix
- Amogh VelangiPhoenix$28K
- Caesar ButuraPhoenix$27K
- Tyler KingPhoenix$6K
- Tjiska ConrottoPhoenix$6K
- Alexander KimPhoenix$5K
- Michael GoldingPhoenix$4K
- Krista LernerPhoenix$3K
- Jon SabolPhoenix$3K
- Joseph CohenPhoenix$2K
- Gordon StableyPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.